©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 110638
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110638
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110638
Table 10 Subgroup analysis of variceal rebleeding risk
- Citation: Abdel Hafez RS, Semeya AA, Elgamal R, Othman AA. Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study. World J Hepatol 2025; 17(11): 110638
- URL: https://www.wjgnet.com/1948-5182/full/v17/i11/110638.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i11.110638